Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Bayer AG banner

Bayer AG
XBSE:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XBSE:BAYN
Watchlist
Price: 141.5 RON 1.8% Market Closed
Market Cap: 139B RON
Write Note Create Alert

Intrinsic Value

Is BAYN undervalued or overvalued?

See the intrinsic value estimate for Bayer AG and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BAYN Intrinsic Value
LOCKED
Unlock
Today vs. history

BAYN looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with BAYN’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BAYN
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price 141.5
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BAYN

Fundamental Analysis

What Bayer Does

Pharmaceuticals Health Care

Bayer AG is a life sciences company that makes medicines and crop protection products. In human health, it sells prescription drugs and consumer health products used for areas like heart disease, women’s health, eye care, and pain relief. In agriculture, it sells seeds, traits, herbicides, fungicides, and digital farming tools that help farmers protect crops and improve yields.

Headquarters
Germany DE
Employees
88 078
IPO date
Nov 28, 1997
Read the full company overview
View Company Overview

Bayer has no economic moat

No Moat Narrow Wide

Patent protection gives Bayer an advantage in some medicines, but it does not prevent cheaper copies from taking business once that protection ends. Competition from generic medicines and crop chemicals limits Bayer’s ability to keep charging higher prices across its businesses.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Bayer AG

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue BAYN Research

Summary
BAYN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BAYN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BAYN stock valuation using valuation multiples.
Wall St Estimates
BAYN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BAYN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Bayer AG listings:
OTC • USD
BAYZF
 OTC • USD
BAYRY
 XETRA • EUR
BAYN
 F • EUR
BAYN
 F • EUR
BAYA
 XHAM • EUR
BAYN
 BMV • MXN
BAYNN
 MIL • EUR
1BAYN
 XMUN • EUR
BAYN
 SWB • EUR
BAYN
 SWB • EUR
BAYA
 DUS • EUR
BAYN
 BET • HUF
BAYER
 XHAN • EUR
BAYN
Discover More
What is the Intrinsic Value of one BAYN stock?

The intrinsic value for Bayer AG (BAYN) under the Base Case is hidden RON.

Is BAYN stock undervalued or overvalued?

Compared with the current market price of 141.5 RON, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.